books search
books
articles search
articles
Donate
Log In
Log In
to access more features
personal recommendations
Telegram Bot
download history
send to Email or Kindle
manage booklists
save to favorites
Explore
Journals
Contribution
Donate
Litera Library
Donate paper books
Add paper books
Open LITERA Point
Volume 20; Issue 1
Main
Current Cancer Drug Targets
Volume 20; Issue 1
Current Cancer Drug Targets
Volume 20; Issue 1
1
Natural DNA Intercalators as Promising Therapeutics for Cancer and Infectious Diseases
Godzieba, Martyna
,
Ciesielski, Slawomir
Journal:
Current Cancer Drug Targets
Year:
2020
Language:
english
File:
PDF, 1.96 MB
Your tags:
english, 2020
2
Anti-VEGF/VEGFR2 Monoclonal Antibodies and their Combinations with PD-1/PD-L1 Inhibitors in Clinic
Gao, Feng
,
Yang, Chun
Journal:
Current Cancer Drug Targets
Year:
2020
Language:
english
File:
PDF, 1.84 MB
Your tags:
english, 2020
3
Sam68 Promotes the Progression of Human Breast Cancer through inducing Activation of EphA3
Chen, Xinxin
,
Zhang, Lehong
,
Yuan, Min
,
Kuang, Ziqiao
,
Zou, Ying
,
Tang, Tian
,
Zhang, Wangjian
,
Hu, Xiaowu
,
Xia, Ting
,
Cao, Tengfei
,
Jia, Haixia
Journal:
Current Cancer Drug Targets
Year:
2020
File:
PDF, 3.97 MB
Your tags:
2020
4
C/EBPα Regulates FOXC1 to Modulate Tumor Growth by Interacting with PPARγ in Hepatocellular Carcinoma
Xu, Zhuo
,
Meng, Shao-Hua
,
Bai, Jian-Guo
,
Sun, Chao
,
Zhao, Li-Li
,
Tang, Rui-Feng
,
Yin, Zhao-Lin
,
Ji, Jun-Wei
,
Yang, Wei
,
Ma, Guang-Jun
Journal:
Current Cancer Drug Targets
Year:
2020
File:
PDF, 3.25 MB
Your tags:
2020
5
ERGIC3 Silencing Additively Enhances the Growth Inhibition of BFA on Lung Adenocarcinoma Cells
Zhao, Qiurong
,
Wu, Mingsong
,
Zheng, Xiang
,
Yang, Lei
,
Zhang, Zhimin
,
Li, Xueying
,
Chen, Jindong
Journal:
Current Cancer Drug Targets
Year:
2020
File:
PDF, 1.92 MB
Your tags:
2020
1
Follow
this link
or find "@BotFather" bot on Telegram
2
Send /newbot command
3
Specify a name for your chatbot
4
Choose a username for the bot
5
Copy an entire last message from BotFather and paste it here
×
×
